Edwards Lifesciences Corporation (EW) Guidance & Earnings Results
On 2026-07-23 Edwards Lifesciences Corporation raised guidance: "FY26 total company constant currency sales growth raised to 10-11% from 9-11%; TAVR constant currency sales growth raised to 8-9% from 7-9%; TMTT sales guidance raised to $760-780M from $740-780M; adjusted EPS…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
EWEdwards Lifesciences CorporationFollow EW — free
—
Price chart with a free account
- Market cap
- 51.3B
- P/E TTM
- 51.2
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 23 Jul 26 | Raised | FY26 total company constant currency sales growth raised to 10-11% from 9-11%; TAVR constant currency sales growth raised to 8-9% from 7-9%; TMTT sales guidance raised to $760-780M from $740-780M; adjusted EPS reaffirmed $2.95-$3.05 · full year |
| 23 Apr 26 | Raised | Constant currency sales growth guidance raised to 9-11% from 8-10%; adjusted EPS guidance raised to $2.95-$3.05 from $2.90-$3.05 · full year |
| 10 Feb 26 | Raised | FY2026 constant currency sales growth 8-10%, adj. EPS $2.90-$3.05, TMTT $740-$780M · full year |
| 30 Oct 25 | Raised | FY2025 sales growth raised to high end of 9-10%; TAVR to 7-8%; adjusted EPS to $2.56-$2.62 · full year |
| 24 Jul 25 | Raised | FY2025 sales growth raised to 9-10% from 8-10%; TAVR growth raised to 6-7% from 5-7%; adjusted EPS to high-end of $2.40-$2.50; Q3 sales $1.46-$1.54B; Q3 adjusted EPS $0.54-$0.60 · full year |
Edwards Lifesciences Corporation — questions
- What guidance did Edwards Lifesciences Corporation give?
- On 2026-07-23: "FY26 total company constant currency sales growth raised to 10-11% from 9-11%; TAVR constant currency sales growth raised to 8-9% from 7-9%; TMTT sales guidance raised to $760-780M from $740-780M; adjusted EPS reaffirmed $2.95-$3.05"
- When does Edwards Lifesciences Corporation report earnings?
- Edwards Lifesciences Corporation's next earnings report is expected on 2026-11-04.
Every figure on this page comes from Edwards Lifesciences Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.